| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1662207 | F | Antiviral activity against Human coronavirus OC43 infected in human HRT18 cells after 4 days by qRT-PCR analysis | Human coronavirus OC43 | 1 | ALA1649558 | cell-based format | Scientific Literature | |
| 2. | ALA1662210 | F | Antiviral activity against Human coronavirus OC43 infected in human HRT18 cells assessed as decrease in viral load at 10 uM treated at the time of infection measured after 28 hrs by qRT-PCR analysis relative to control | Human coronavirus OC43 | 1 | ALA1649558 | cell-based format | Scientific Literature | |
| 3. | ALA1662211 | F | Antiviral activity against Human coronavirus OC43 infected in pregnant C57BL/6 mouse assessed as survival rate at 15 mg/kg, sc administered prepartum | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 4. | ALA1662212 | F | Antiviral activity against Human coronavirus OC43 infected in pregnant C57BL/6 mouse assessed as survival rate at 15 mg/kg, sc administered postpartum | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 5. | ALA1662213 | F | Antiviral activity against Human coronavirus OC43 infected in pregnant C57BL/6 mouse assessed as survival rate at 5 mg/kg, sc administered prepartum | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 6. | ALA1662214 | F | Antiviral activity against Human coronavirus OC43 infected in pregnant C57BL/6 mouse assessed as survival rate at 5 mg/kg, sc administered postpartum | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 7. | ALA1662215 | F | Antiviral activity against Human coronavirus OC43 infected in pregnant C57BL/6 mouse assessed as survival rate at 1 mg/kg, sc administered prepartum | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 8. | ALA1662216 | F | Antiviral activity against Human coronavirus OC43 infected in pregnant C57BL/6 mouse assessed as survival rate at 1 mg/kg, sc administered postpartum | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 9. | ALA1662217 | F | Antiviral activity against Human coronavirus OC43 infected in new born C57BL/6 mouse assessed as survival rate at 15 mg/kg, sc transfered via placenta after administration to pregnant mouse | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 10. | ALA1662218 | F | Antiviral activity against Human coronavirus OC43 infected in new born C57BL/6 mouse assessed as survival rate at 15 mg/kg, sc transfered via maternal milk after administration to pregnant mouse | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 11. | ALA1662219 | F | Antiviral activity against Human coronavirus OC43 infected in new born C57BL/6 mouse assessed as survival rate at 5 mg/kg, sc transfered via placenta after administration to pregnant mouse | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 12. | ALA1662220 | F | Antiviral activity against Human coronavirus OC43 infected in new born C57BL/6 mouse assessed as survival rate at 5 mg/kg, sc transfered via maternal milk after administration to pregnant mouse | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 13. | ALA1662221 | F | Antiviral activity against Human coronavirus OC43 infected in new born C57BL/6 mouse assessed as survival rate at 1 mg/kg, sc transfered via placenta after administration to pregnant mouse | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 14. | ALA1662222 | F | Antiviral activity against Human coronavirus OC43 infected in new born C57BL/6 mouse assessed as survival rate at 1 mg/kg, sc transfered via maternal milk after administration to pregnant mouse | Human coronavirus OC43 | 1 | ALA1649558 | organism-based format | Scientific Literature | |
| 15. | ALA3238841 | F | Inhibition of Human coronavirus OC43 replication infected in human 293T cells transfected with wild-type HCoV-OC43 N protein assessed as M mRNA level at 10 uM by RT-PCR analysis (Rvb = 2.41 no unit) | Human coronavirus OC43 | 2 | ALA3232913 | cell-based format | Scientific Literature | |
| 16. | ALA3238924 | F | Inhibition of Human coronavirus OC43 replication infected in human 293T cells assessed as M mRNA level at 10 uM by RT-PCR analysis (Rvb = 0.32 no unit) | Human coronavirus OC43 | 2 | ALA3232913 | cell-based format | Scientific Literature | |
| 17. | ALA4723135 | F | Antiviral activity against wild type HCoV-OC43 infected in BHK-21 cells incubated for 72 hrs by RT-PCR method | Human coronavirus OC43 | 8 | ALA4715853 | cell-based format | Scientific Literature | |
| 18. | ALA4723140 | F | Antiviral activity against wild type HCoV-OC43 infected in human Huh-7 cells preincubated for 1 hrs followed by overlaying with reduced-serum Medium and measured after 72 hrs ELISpot assay | Human coronavirus OC43 | 1 | ALA4715853 | cell-based format | Scientific Literature | |
| 19. | ALA4723190 | F | Antiviral activity against HCoV-OC43 infected in human MRC-5 cells measured after 4 days by MTS assay | Human coronavirus OC43 | 3 | ALA4715853 | cell-based format | Scientific Literature | |
| 20. | ALA4723193 | F | Antiviral activity against HCoV-OC43 infected in BALB/c mouse assessed as protection against virus-induced lethal infection at 15 mg/kg, ip administered for 14 days and measured up to 20 days | Human coronavirus OC43 | 1 | ALA4715853 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!